Specifically, the same study also showed that JNK3 strongly co-localizes with Aβ plaques in the frontal cortex of AD patients, and JNK3 expression was upregulated; on the other hand, no significant changes for JNK1 and JNK2 were found. Here, MAPK8 is linked to Alzheimer disease.